Vancouver, B.C., June 17, 2021 – Further to its press release date May 17, 2021, Awakn Life Sciences Corp. (formerly 1169082 B.C. Ltd.) (the “Company”) is pleased to announce that it has completed its reverse takeover transaction (the “Transaction”) of Awakn Life Sciences Inc. (“Awakn”), and that the net proceeds from its previously announced brokered private placement of 3,320…

Source

Previous articleSilo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Announces Psychedelics Genetic Test Kit Partnership
Next articleDiamond Therapeutics contracts BioPharma Services for Phase 1 clinical trial